Cefquinome is a fourth-generation cephalosporin with pharmacological and antibacterial properties valuable in the treatment of coliform mastitis and other infections. It is only used in …

Cefquinome is a semisynthetic, broad-spectrum, fourth-generation aminothiazolyl cephalosporin with antibacterial activity. Cefquinome binds to and inactivates penicillin -binding proteins …

Cefquinome is used in cattle, pigs, and horses to treat infections caused by susceptible pathogens. It is registered in Europe for treatment of respiratory disease, E. coli sepsis in …

Cefquinome is a fourth generation cephalosporin applied as veterinary medicine solely. Cefquinome is stable to common plasmid- and chromosomally mediated beta-lactamases …

Cefquinome (1.0 mg/kg) was administered by intravenous and intramuscular routes to six healthy thoroughbred foals. Serum cefquinome concentrations were determined by high-performance …

Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs. Journal of Veterinary Pharmacology and Therapeutics , 38 (6), 543–548. …

Cefquinome (CEQ), a fourth generation of cephalosporins, is solely developed for veterinary use. CEQ can interrupt cell wall formation and exert excellent antibacterial effects on both gram …

Cefquinome (CEQ) is a novel β-lactam antibiotic that exhibits excellent antibacterial activity against Staphylococcus aureus. However, the bacterial protein targets of CEQ are unclear.

Cefquinome is a fourth-generation cephalosporin with pharmacological and antibacterial properties valuable in the treatment of coliform mastitis and other infections. It is only used in …

Oct 7, 2016 · Cefquinome is a semisynthetic β-lactam antibiotic and fourth-generation cephalosporin developed for use in veterinary medicine. It is stable to common plasmid- and …